These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 116791)

  • 41. [The effect of nitroglycerin in patients with acute myocardial infarction. IV. Myocardon in patients with and without left ventricular failure (author's transl)].
    Bussmann WD; Löhner J; Kaltenbach M
    Med Klin; 1976 Mar; 71(10):421-8. PubMed ID: 817116
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increase of cardiac output by afterload reduction in patients with severe congestive heart failure using nitroglycerin discs. A double-blind placebo-controlled haemodynamic study.
    Heikkilä J; Pellinen TJ; Blake P; McAllister A; Yardley J
    Ann Clin Res; 1987; 19(3):203-7. PubMed ID: 3118755
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanism of action of nitrates. Role of changes in venous capacitance and in the left ventricular diastolic pressure-volume relation.
    Smith ER; Smiseth OA; Kingma I; Manyari D; Belenkie I; Tyberg JV
    Am J Med; 1984 Jun; 76(6A):14-21. PubMed ID: 6430073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Nitroglycerin in the therapy of coronary insufficiency and heart failure].
    Kaltenbach M; Bussmann WD; Kober G
    Z Kardiol; 1976 May; 65(5):424-34. PubMed ID: 820103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of intravenous nitroglycerin on hemodynamics and ischemic injury in patients with acute myocardial infarction.
    Bussmann WD; Schöfer H; Kaltenbach M
    Eur J Cardiol; 1978 Aug; 8(1):61-74. PubMed ID: 99309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aspects on "traditional" vasodilators in the treatment of chronic heart failure.
    Rydén L; Conradson TB
    Acta Med Scand Suppl; 1986; 707():85-90. PubMed ID: 3526822
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short- and long-term effects of hydralazine and combined hydralazine-prenalterol therapy in severe chronic congestive heart failure.
    Drexler H; Löllgen H; Just H
    Klin Wochenschr; 1981 Jun; 59(12):647-54. PubMed ID: 7253539
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hydralazine in heart failure.
    Chatterjee K
    Herz; 1983 Aug; 8(4):187-98. PubMed ID: 6413340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The treatment of congestive heart failure by using vasodilators. I. Physiological basis. Different vasodilators (author's transl)].
    Solignac A
    Nouv Presse Med; 1978 Mar; 7(12):1013-20. PubMed ID: 96422
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of nitroglycerin ointment on hemodynamics in patients with mitral insufficiency.
    Gould L; Reddy CV; Zen B; Singh BK
    Angiology; 1980 Oct; 31(10):677-85. PubMed ID: 6778263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hemodynamic effects of hydralazine in the cardiac insufficiency of non-obstructive myocardiopathy].
    Pailloncy M; Fernandez F; Lelguen C; Datchary J; Ponsonnaille J; Gerbaux A; Gras H
    Arch Mal Coeur Vaiss; 1979 Mar; 72(3):276-83. PubMed ID: 114138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hydralazine therapy in chronic congestive heart failure. Sustained central and regional hemodynamic responses.
    Magorien RD; Unverferth DV; Leier CV
    Am J Med; 1984 Aug; 77(2):267-74. PubMed ID: 6431812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of intravenous administration of nitroglycerin and regitine on hemodynamics in mitral valve insufficiency].
    Korewicki J; Rajecka A; Pogorzelska H; Madeja G
    Kardiol Pol; 1990; 33(6):365-74. PubMed ID: 2128094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of intravenous nitroglycerin on hemodynamics in infants and children with congestive heart failure.
    Zeng H; Sun L; Li W; Du J
    Chin Med J (Engl); 2000 Apr; 113(4):328-31. PubMed ID: 11775229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Differential use of peripheral vasodilators in the treatment of chronic circulatory failure in patients with mitral valve insufficiency].
    Zhilin SV; Vorob'ev BI; Kastanaian AA; Masalitinova IV
    Kardiologiia; 1990 Mar; 30(3):101-3. PubMed ID: 2116542
    [No Abstract]   [Full Text] [Related]  

  • 56. Hydralazine does not ameliorate nitric oxide resistance in chronic heart failure.
    Chirkov YY; De Sciscio M; Sverdlov AL; Leslie S; Sage PR; Horowitz JD
    Cardiovasc Drugs Ther; 2010 Apr; 24(2):131-7. PubMed ID: 20490904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Noninvasive assessment of left ventricular effects of hydralazine in heart failure.
    Deglin SM; Jain AC; Harris WS
    Cardiology; 1980; 66(4):193-8. PubMed ID: 7448835
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination of Hydralazine and Isosorbide-Dinitrate in the Treatment of Patients with Heart Failure with Reduced Ejection Fraction.
    Nyolczas N; Dékány M; Muk B; Szabó B
    Adv Exp Med Biol; 2018; 1067():31-45. PubMed ID: 29086392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Different hemodynamic effects of atrial natriuretic factor and nitroglycerin in rats with congestive heart failure.
    Chien YW; Trippodo NC; Frohlich ED
    Am J Physiol; 1989 Dec; 257(6 Pt 2):R1481-7. PubMed ID: 2532483
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sustained salutary effects of oral controlled-release nitroglycerin on ventricular function in congestive heart failure.
    Amsterdam EA; Awan NA; DeMaria AN; Miller RR; Williams DO; Mason DT
    Clin Cardiol; 1979 Feb; 2(1):19-25. PubMed ID: 115631
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.